Hosptial Acquired Pneumonia: Clinical Trials

1 trial for Hosptial Acquired Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Hosptial Acquired Pneumonia: new trials by email Literature Review of Hosptial Acquired Pneumonia trials Research Report on Hosptial Acquired Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia
Phase 3CompletedPfizer4222018-04-052024-12-10

Narrower conditions

Pneumonia, Ventilator-Associated (1)

Broader conditions

Cross Infection (1)  ·  Disease Attributes (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Sponsors

Pfizer (1)

Countries

Argentina (1)  ·  Bulgaria (1)  ·  China (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Philippines (1)  ·  Romania (1)  ·  Russia (1)  ·  South Korea (1)

Results publications

PMID 38252170, PMID 39389071, PMID 40530972, PMID 41269522

NIH funding

2017 (1)